Cargando…
Should Canadian patients look forward to aducanumab for Alzheimer disease?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Joule Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443286/ https://www.ncbi.nlm.nih.gov/pubmed/34518345 http://dx.doi.org/10.1503/cmaj.211134 |
| _version_ | 1783753154021556224 |
|---|---|
| author | Watt, Jennifer A. Marple, Roger Hemmelgarn, Brenda Straus, Sharon E. |
| author_facet | Watt, Jennifer A. Marple, Roger Hemmelgarn, Brenda Straus, Sharon E. |
| author_sort | Watt, Jennifer A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8443286 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | CMA Joule Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84432862021-09-17 Should Canadian patients look forward to aducanumab for Alzheimer disease? Watt, Jennifer A. Marple, Roger Hemmelgarn, Brenda Straus, Sharon E. CMAJ Commentary CMA Joule Inc. 2021-09-13 /pmc/articles/PMC8443286/ /pubmed/34518345 http://dx.doi.org/10.1503/cmaj.211134 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Commentary Watt, Jennifer A. Marple, Roger Hemmelgarn, Brenda Straus, Sharon E. Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title | Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title_full | Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title_fullStr | Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title_full_unstemmed | Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title_short | Should Canadian patients look forward to aducanumab for Alzheimer disease? |
| title_sort | should canadian patients look forward to aducanumab for alzheimer disease? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443286/ https://www.ncbi.nlm.nih.gov/pubmed/34518345 http://dx.doi.org/10.1503/cmaj.211134 |
| work_keys_str_mv | AT wattjennifera shouldcanadianpatientslookforwardtoaducanumabforalzheimerdisease AT marpleroger shouldcanadianpatientslookforwardtoaducanumabforalzheimerdisease AT hemmelgarnbrenda shouldcanadianpatientslookforwardtoaducanumabforalzheimerdisease AT straussharone shouldcanadianpatientslookforwardtoaducanumabforalzheimerdisease |